Opinion|Videos|December 22, 2023
The Real-World Effectiveness of Treatment with Teclistamab for Patients with R/R MM
Author(s)Danai Dima, MD
Discussion of the real-world effectiveness of teclistamab in R/R MM and the impact on treatment guidelines and practice.
Advertisement
Advertisement
Related to this article
During a live event, Rushang Patel, MD, PhD, and participants discussed referral timing, bridging, and payer barriers that shape access to cellular therapy in early relapsed multiple myeloma.
Advertisement
Advertisement
Trending on Targeted Onc
1
Temab-A Shows Promising Survival in Pretreated Nonsquamous NSCLC
2
Referral Before Salvage Therapy Keeps CAR T an Option in Myeloma
3
FDA Grants RMAT and Fast Track Status to Prizlon-Cel in R/R LBCL
4
DeLLphi-305 Sets a New Standard, and the Bar Is Rising in SCLC
5